Total Funding
30
49
Total FundingGrant raised
Growth Score
-9 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
174366
Rhythm Biotherapeutics Inc. is developing innovative medications to prevent and treat atrial fibrillation.
About the Company
Rhythm Biotherapeutics is a preclinical-stage firm that aims to solve a key unmet need by preventing and treating atrial fibrillation, a chronic, progressive, debilitating, and life-threatening condition. Our initial focus is on a preventative solution for postoperative atrial fibrillation. RBex is a preventive exosome treatment that has shown an
87% reduction in postoperative atrial fibrillation in comprehensive and published preclinical trials. We are now soliciting funds to conduct a first-in-human phase 1 clinical trial.
